PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Closed 04-20 16:00:00 EDT

25.73

+0.59

+2.35%

盘后25.94

+0.21+0.81%

19:38 EDT

High25.97	Low24.80	Vol1.04M
Open24.97	D1 Closing25.14	Amplitude4.67%
Mkt Cap1.45B	Tradable Cap1.38B	Total Shares56.39M
T/O26.60M	T/O Rate1.94%	Tradable Shares53.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":25.73,"timestamp":1776715200000,"preClose":25.14,"halted":0,"volume":1037588,"hourTrading":{"tag":"盘后","latestPrice":25.9376,"preClose":25.73,"latestTime":"19:38 EDT","volume":88708,"amount":2282414.08,"timestamp":1776728339018,"change":0.2076,"changeRate":0.008068,"amplitude":0.039195},"delay":0,"changeRate":0.023468575974542556,"floatShares":53564164,"shares":56390196,"eps":-1.720653,"marketStatus":"Closed","change":0.59,"latestTime":"04-20 16:00:00 EDT","open":24.97,"high":25.97,"low":24.795,"amount":26602729.10788,"amplitude":0.046738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.720653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776758400000},"marketStatusCode":5,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":25.14,"preHourTrading":{"tag":"盘前","latestPrice":24.97,"preClose":25.14,"latestTime":"09:29 EDT","volume":2505,"amount":62575.78677,"timestamp":1776691799999,"change":-0.17,"changeRate":-0.006762,"amplitude":0.033015},"postHourTrading":{"tag":"盘后","latestPrice":25.9376,"preClose":25.73,"latestTime":"19:38 EDT","volume":88708,"amount":2282414.08,"timestamp":1776728339018,"change":0.2076,"changeRate":0.008068,"amplitude":0.039195},"volumeRatio":0.937124,"impliedVol":0.8612,"impliedVolPercentile":0.8924},"requestUrl":"/m/hq/s/PRCT/tweets","defaultTab":"tweets","newsList":[{"id":"2627665612","title":"PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2627665612","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627665612?lang=en_us&edition=fundamental","pubTime":"2026-04-16 13:07","pubTimestamp":1776316068,"startTime":"0","endTime":"0","summary":"In the past quarter, PROCEPT BioRobotics reported strong third-quarter 2025 execution and issued fiscal 2026 revenue expectations of US$410 million to US$430 million, while management detailed organizational changes to accelerate new account launches and boost therapy awareness.\nBeyond the headline numbers, the company’s emphasis on improving procedure utilization to unlock longer-term value highlights how management is targeting deeper engagement within its existing customer base rather...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-75-after-raising-2026-revenue","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-75-after-raising-2026-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626305591","title":"Procept BioRobotics to report first-quarter results, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2626305591","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626305591?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:09","pubTimestamp":1775765342,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics schedules Q1 2026 financial results for April 29, 2026.Management conference call set for 4:30 p.m. ET on April 29, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL3JFS1h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BK4585","LU0314104364.USD","BK4082","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU2324357040.USD","BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","NDAQ","SG9999014021.USD","SG9999014005.SGD","PRCT","IE00BGHQF748.EUR","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626536061","title":"PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626536061","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626536061?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:05","pubTimestamp":1775765100,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., April  09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transf","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3271412/0/en/PROCEPT-BioRobotics-to-Report-First-Quarter-2026-Financial-Results-on-April-29-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622388831","title":"How Investors May Respond To PROCEPT BioRobotics (PRCT) Winning Strong EAU Backing For Aquablation","url":"https://stock-news.laohu8.com/highlight/detail?id=2622388831","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622388831?lang=en_us&edition=fundamental","pubTime":"2026-03-26 14:06","pubTimestamp":1774505193,"startTime":"0","endTime":"0","summary":"Earlier in March 2026, PROCEPT BioRobotics highlighted that the European Association of Urology has upgraded Aquablation therapy to a strong recommendation as a surgical option for men with benign prostatic hyperplasia, positioning it as an alternative to transurethral resection of the prostate, especially for those seeking to preserve ejaculatory function.\nThis guideline upgrade, backed by multiple WATER clinical trials and growing international validation including NICE support in the UK,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/how-investors-may-respond-to-procept-biorobotics-prct-winnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/how-investors-may-respond-to-procept-biorobotics-prct-winnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIPO","LU2324357040.USD","ISBC","PRCT","BK4082","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621717505","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621717505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621717505?lang=en_us&edition=fundamental","pubTime":"2026-03-22 20:40","pubTimestamp":1774183225,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Merck & Company (MRK), Chemed (CHE) and PROCEPT BioR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-chemed-che-and-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-chemed-che-and-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","LU1989772923.USD","SG9999015358.SGD","LU0965508806.USD","LU0265550946.USD","SG9999014559.SGD","LU1093756168.USD","SG9999014567.USD","LU1620156130.USD","LU1291159041.SGD","LU0128526141.USD","LU0070302665.USD","LU0980610538.SGD","LU0985320562.USD","IE00B64QTZ34.USD","LU1917777945.USD","LU1066051498.USD","SG9999015341.SGD","LU1929549753.HKD","LU2125154935.USD","LU2361044949.HKD","LU2361045086.USD","LU0648001328.SGD","LU1066051225.USD","LU0965509283.SGD","LU1983299246.USD","LU1162221912.USD","LU2413666004.HKD","LU0029874061.USD","LU0130102774.USD","SG9999002224.SGD","LU1699723380.USD","LU0942090050.USD","LU1941712264.USD","SGXZ57979304.SGD","LU2023250843.SGD","LU1037948541.HKD","BK4559","LU0432979614.USD","LU1571399168.USD","LU2461242641.AUD","LU0006306889.USD","LU2468319806.SGD","LU2413665964.HKD","LU1941712348.USD","LU1989772840.SGD","LU0106261372.USD","BK4196","LU0868494617.USD","IE00BBT3K403.USD","LABU","SG9999001176.SGD","BK4516","LU1974910355.USD","LU1721427968.SGD","IE00BLSP4239.USD","LU1037948897.HKD","LU2112291526.USD","LU1934455194.USD","LU1066051811.HKD","LU2324357040.USD","LU1035773651.USD","SG9999014542.SGD","LU0058720904.USD","BK4082","IE00BLSP4452.SGD","SG9999013999.USD","BK4585","LU0868494708.USD","LU2125154778.USD","LU0477156953.USD","IE0002141913.USD","LU0203347892.USD","MRK","LU1934455277.USD","LU1620156213.USD","LU1596574779.USD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU0208291251.USD","LU1116320901.HKD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU0861579265.USD","LU1989771016.USD","LU0098860793.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","BK4550","LU1934455863.HKD","LU2361044865.SGD","LU1093756325.SGD","IE00BJJMRZ35.SGD","BK4533","IE000M9KFDE8.USD","LU0234572021.USD","SG9999002232.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0965509010.AUD","LU0122379950.USD","LU1066053197.SGD","LU2089984988.USD","LU0320765646.SGD","SG9999001176.USD","LU1116320737.USD","LU1201861249.SGD","LU0265550359.USD","LU2360032135.SGD","LU1061106388.HKD","PRCT","XBI","LU0203345920.USD","LU0211331839.USD","LU2023250504.SGD","CHE","LU1585245621.USD","SG9999014575.USD","LU0266013472.USD","LU1023059063.AUD","LU1069347547.HKD","LU1165135440.EUR","LU2106854487.HKD","IE00BFTCPJ56.SGD","LU0965509101.SGD","IE00BLDYK493.USD","LU0289739699.SGD","LU1543694498.USD","IE00B2B36J28.USD","BK4588","BK4137","IE00BSNM7G36.USD","BK4007","IE0009355771.USD","BK4534","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620206389","title":"Top Executive Quietly Unloads PROCEPT BioRobotics Shares in Notable Insider Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2620206389","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620206389?lang=en_us&edition=fundamental","pubTime":"2026-03-20 10:08","pubTimestamp":1773972517,"startTime":"0","endTime":"0","summary":"New insider activity at PROCEPT BioRobotics ( ($PRCT) ) has taken place on March 19, 2026. PROCEPT BioRobotics’ Executive Vice President and Chief ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-quietly-unloads-procept-biorobotics-shares-in-notable-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-quietly-unloads-procept-biorobotics-shares-in-notable-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620827465","title":"Procept BioRobotics EVP, CLO and Corporate Secretary Nouri Alaleh disposes of USD 138,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620827465","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620827465?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:47","pubTimestamp":1773956862,"startTime":"0","endTime":"0","summary":"Nouri Alaleh, EVP, CLO and corporate secretary at Procept BioRobotics, reported sales of common stock.Alaleh sold 3,031 shares at a weighted average price of USD 25.82 per share.A separate transaction reported the sale of 2,332 shares at a weighted average price of USD 26.15 per share.Following the reported transactions, Alaleh beneficially owned 105,354 shares of common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL3Mkj6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Procept BioRobotics EVP, CLO and Corporate Secretary Nouri Alaleh disposes of USD 138,000 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620118223","title":"Levi & Korsinsky Investigates Procept BioRobotics After USD 17.4 Million Revenue Shortfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2620118223","media":"Reuters","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620118223?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:00","pubTimestamp":1773925249,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky is investigating Procept BioRobotics over statements tied to a USD 325.5 million revenue target that was followed by reported revenue of USD 308.1 million.The firm said CFO Kevin Waters reaffirmed the revenue target and referenced handpiece average selling prices of about USD 3,200.According to the investigation notice, Procept had implemented a pricing initiative that removed bulk-purchase discounts, which the firm said reduced realized average selling prices.The notice said the revenue shortfall was followed by a share-price drop of more than 15%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLbPdQjx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","IE00BN0W2T93.GBP","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210150020.SGD","NDAQ","BK4588","BK4112","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","BK4082","LU2324357040.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620477779","title":"Why PROCEPT BioRobotics (PRCT) Is Up 10.8% After Expanding Its AI-Enabled HYDROS System Internationally","url":"https://stock-news.laohu8.com/highlight/detail?id=2620477779","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620477779?lang=en_us&edition=fundamental","pubTime":"2026-03-18 02:14","pubTimestamp":1773771263,"startTime":"0","endTime":"0","summary":"Earlier this month, PROCEPT BioRobotics announced the international expansion of its HYDROS Robotic System, an AI-enabled platform that delivers Aquablation therapy for benign prostatic hyperplasia using real-time ultrasound imaging and robotic-assisted, anatomy-specific treatment planning.\nThis move reinforces PROCEPT’s focus on combining AI, robotics and imaging to support consistent, scalable BPH procedures while aiming to preserve patients’ sexual and urinary function.\nNext, we’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/why-procept-biorobotics-prct-is-up-108-after-expanding-its-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/why-procept-biorobotics-prct-is-up-108-after-expanding-its-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","BK4082","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619543573","title":"Levi & Korsinsky probes Procept BioRobotics over possible federal securities law violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2619543573","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619543573?lang=en_us&edition=fundamental","pubTime":"2026-03-16 12:28","pubTimestamp":1773635336,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky said it has opened an investigation into Procept BioRobotics over potential federal securities law violations. The firm cited comments by CFO Kevin Waters and CEO Larry Wood on a Q3 2025 earnings call that reaffirmed a USD 325.5 million revenue target and referenced maintaining handpiece average selling prices of about USD 3,200. It alleged the company had implemented a pricing-discipline initiative that eliminated bulk-purchase discounts, which it said reduced realized average selling prices. Levi & Korsinsky said Q4 2025 revenue was USD 17.4 million below guidance and FY 2026 revenue guidance of USD 410 million to USD 430 million was below analyst consensus. It also said the stock fell roughly 15% in a single session after the Q4 2025 results release.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL6SZ5HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132994","title":"Procept Biorobotics® Announces International Launch of the Hydros® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132994?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:00","pubTimestamp":1773320404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA6JSFQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618488132","title":"PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618488132","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618488132?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:00","pubTimestamp":1773320400,"startTime":"0","endTime":"0","summary":"UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March  12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasd","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3254771/0/en/PROCEPT-BioRobotics-Announces-International-Launch-of-the-HYDROS-Robotic-System-Expanding-Global-Access-to-AI-Enabled-Aquablation-Therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BPH","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618695928","title":"Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618695928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618695928?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:24","pubTimestamp":1773149048,"startTime":"0","endTime":"0","summary":"In late February 2026, PROCEPT BioRobotics reported fourth quarter and full-year 2025 results showing higher sales but a larger net loss, and issued 2026 guidance calling for US$390 million to US$410 million in revenue, gross margin of about 65%, and a net loss of US$78,500,000 to US$91,500,000.\nAlongside this guidance, the company outlined 2027 targets, including 25% to 30% annual revenue growth and 68% to 70% gross margin, and soon after expanded its board to nine members by appointing...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/is-procepts-growth-targets-and-new-cfo-director-altering-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/is-procepts-growth-targets-and-new-cfo-director-altering-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617068712","title":"Baird Initiates PROCEPT BioRobotics at Neutral With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2617068712","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617068712?lang=en_us&edition=fundamental","pubTime":"2026-03-06 20:22","pubTimestamp":1772799772,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $32.92, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617684565","title":"Procept BioRobotics names Daniel Puckett to board and audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2617684565","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617684565?lang=en_us&edition=fundamental","pubTime":"2026-03-06 19:02","pubTimestamp":1772794964,"startTime":"0","endTime":"0","summary":"Procept BioRobotics increased its board size to nine members and appointed Daniel Puckett as a new director. Puckett was also appointed to the board’s Audit Committee, effective immediately. He previously served as CFO of Shockwave Medical from April 2016 until his retirement in February 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL8k33nK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU2129689431.USD","LU0234572021.USD","LU2430703251.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU1935042991.SGD","PRCT","BK4007","JNJ","IE00BLSP4239.USD","LU1430594728.SGD","LU2324357040.USD","LU1674673691.USD","LU2089984988.USD","SG9999002224.SGD","LU1066051811.HKD","LU0289739699.SGD","LU1221951046.USD","LU2750360997.AUD","BK4568","LU0912757837.SGD","BK4532","LU1244550221.USD","BK4504","LU1061106388.HKD","BK4533","LU1244550577.SGD","LU1059921491.USD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU1506573853.SGD","LU0345770993.USD","LU2471134796.USD","LU0234570918.USD","BK4082","LU0070217475.USD","LU0882574055.USD","LU1674673428.USD","LU2133065610.SGD","LU1162221912.USD","LU0689626769.HKD","SG9999002232.USD","LU1894683348.USD","LU2112291526.USD","IE00BFXG1179.USD","IE0034235303.USD","LU2468319806.SGD","LU0795875169.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617681098","title":"PROCEPT BioRobotics Initiated at Neutral by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2617681098","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617681098?lang=en_us&edition=fundamental","pubTime":"2026-03-06 18:50","pubTimestamp":1772794200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 05:50 ET (10:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617268181","title":"Procept BioRobotics initiated with a Neutral at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2617268181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617268181?lang=en_us&edition=fundamental","pubTime":"2026-03-06 18:20","pubTimestamp":1772792449,"startTime":"0","endTime":"0","summary":"Baird last night initiated coverage of Procept BioRobotics (PRCT) with a Neutral rating and $30 price target The firm says “several recent headwind...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-a-neutral-at-baird-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-a-neutral-at-baird-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4082","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616837909","title":"Levi & Korsinsky Launches Fraud Probe Into Procept BioRobotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616837909","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616837909?lang=en_us&edition=fundamental","pubTime":"2026-03-04 04:45","pubTimestamp":1772570727,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has opened a federal securities-law investigation into Procept Biorobotics Corp. over statements about revenue targets, pricing, and progress toward profitability. The probe follows a pricing change that reduced realized average selling prices, after which the company reported Q4 2025 revenue below prior guidance and issued 2026 revenue guidance that missed analyst expectations, contributing to a sharp one-day stock drop.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL4gc7W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150174240","title":"Stock Track | PROCEPT BioRobotics Plunges 9.39% in After-Hours Trading Following Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1150174240","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150174240?lang=en_us&edition=fundamental","pubTime":"2026-03-03 06:38","pubTimestamp":1772491119,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) experienced a significant after-hours plunge of 9.39% on Monday, following a series of analyst price target reductions published earlier in the day.The post-market decline...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616353521","title":"Procept BioRobotics price target lowered to $30 from $62 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616353521?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:13","pubTimestamp":1772460784,"startTime":"0","endTime":"0","summary":"UBS analyst Danielle Antalffy lowered the firm’s price target on Procept BioRobotics (PRCT) to $30 from $62 and keeps a Buy rating on the shares. P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-price-target-lowered-to-30-from-62-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-price-target-lowered-to-30-from-62-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU3187612489.SGD","LU2324357040.USD","BK4534","BK4118","IE0034235071.USD","BK4585","LU1829250122.USD","LU1863844749.USD","PRCT","UBS","BK4082","BK4588","LU1863844665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":0.0836},{"period":"1month","weight":-0.0394},{"period":"3month","weight":-0.1725},{"period":"6month","weight":-0.2375},{"period":"1year","weight":-0.5259},{"period":"ytd","weight":-0.2009}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.079362},{"month":2,"riseRate":0.4,"avgChangeRate":0.005067},{"month":3,"riseRate":0.6,"avgChangeRate":0.037831},{"month":4,"riseRate":0.8,"avgChangeRate":0.018026},{"month":5,"riseRate":1,"avgChangeRate":0.132144},{"month":6,"riseRate":0.25,"avgChangeRate":-0.048608},{"month":7,"riseRate":0.5,"avgChangeRate":0.00614},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.2,"avgChangeRate":-0.059852}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}